Page has been deleted from My Report

New Residents

Technopolis Moscow SEZ features over 220 high‑tech companies (118 of them have the resident status). Many residents are recognized leaders in their sectors, setting the vector of high‑tech development. Their experience becomes a reference point for new participants.

New residents are always a positive sign in SEZ development, as they bring innovations, boost investments and create new jobs, which contributes to sustainable economic growth of the territory. In 2024, 17 enterprises received the status of a resident of Technopolis Moscow SEZ.

New residents of SEZ Technopolis Moscow

Energy‑efficient technologies

Pechatniki

Renera

Integrator of Rosatom State Corporation in the field of Energy Storage Systems

NPK Simba

Manufacturer of electric batteries and accumulators

Aviation technologies

Rudnevo

MMZ Skorost

Manufacturer of wing assembly parts for MC‑21 aircraft

NPO Rustecdron

Manufacturer of UAVs and control equipment

Avra

Manufacturer of electric motors for UAVs

Digital Lab

Manufacturer of electronics, single‑board computers and peripherals for copter and airplane‑type UAVs

View Lab

Manufacturer of optical equipment for UAVs

Paseka

Manufacturer of lithium‑ion rechargeable batteries for UAVs

Aerospace

Pechatniki

Labs 1440

Manufacturer of satellite communication elements

Building technologies

Tolstopaltsevo

Combinat of Innovative Technologies-MonArch

Manufacturer of reinforced concrete modules for house construction

Microelectronics

Pechatniki, Mikron

Saga Technologies

Manufacturer of innovative self‑service equipment

Industry Solutions

Manufacturer of electronic component base (ECB) for power electronics

Medical technologies

Alabushevo

Zanton MS

Manufacturer of medical devices based on the use of X‑ray, alpha, beta and gamma radiation

Rosatom Implantat

A subsidiary of Rosatom's fuel company TVEL, a manufacturer of titanium implants

MedTi

Manufacturer of titanium implants

Pharmaceuticals

Alabushevo

Rossium BIO

Manufacturer of drugs for the treatment of orphan, genetic and oncologic diseases